News
Hospital outcomes for children with MIS-C unaffected by initial presentation site
May 20, 2021
The length of hospital stay and rate of pediatric ICU admission were not significantly different between the emergency presentation and outpatient presentation groups.
News
Worse outcomes for patients with COPD and COVID-19
May 19, 2021
Worse outcomes include 14-day hospitalization, length of stay, ICU admission, 30-day mortality, and use of mechanical ventilation.
News
Atorvastatin: A potential treatment in COVID-19?
May 19, 2021
Atorvastatin was not associated with any significant differences in any of the individual components of the primary composite endpoint.
News
Procalcitonin-guided antibiotic stewardship for lower respiratory tract infection
May 18, 2021
For hospitalists, the most clinically useful role for PCT testing is to guide the duration of antibiotic therapy.
News
COVID-19 in children: Weekly cases drop to 6-month low
May 18, 2021
No increase seen in children’s share of weekly and cumulative cases.
News
Dr. Fauci: Extraordinary challenges, scientific triumphs with COVID-19
May 18, 2021
“The speed and efficiency with which these highly efficacious vaccines were developed, and their potential for saving millions of lives, are due to an extraordinary multidisciplinary effort.”
News
FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
May 18, 2021
A prespecified, exploratory analysis from the FIDELIO-DKD trial showed that the nonsteroidal MRA finerenone significantly cut new-onset AFib.
News
Dapagliflozin misses as treatment for COVID-19 but leaves intriguing signal for benefit
May 18, 2021
The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close.
Opinion
Planning for SHM Converge 2022 now underway
May 17, 2021
SHM Converge 2022, scheduled for April 2002 in Nashville, will be the first in-person annual conference in three years.
News
Omics analysis links blood type to COVID-19
May 17, 2021
Within the ABO gene, the research also turned up evidence that blood type O may be protective against COVID-19.